The latest in brief
Initiative “#Zusammenland – Diversity makes us strong”: conzima is part of it!

In recent weeks, hundreds of thousands of people have taken to the streets in Germany to take a stand against right-wing extremism - and at the same time to show their support for freedom, diversity and a welcoming culture. And because taking a stand is more important than ever in these times, DIE ZEIT, Handelsblatt, Süddeutsche Zeitung, Tagesspiegel, WirtschaftsWoche and Ströer have launched the “#Zusammenland - Vielfalt macht uns stark” campaign. Over 500 companies, foundations, associations and NGOs are taking part - including conzima. Because we all know: Populism, nationalist and right-wing extremist ideas not only harm democracy, but also the economy. Germany is dependent on people from all over the world who would like to live and work here.
The campaign was launched on February 15, 2024 with a double-page spread in newspapers and on digital outdoor advertising throughout Germany. After the launch, both motifs will continue to be published regularly in newspapers, in public spaces and on social media.
“Vaccinate. Now!” Conzima supports the Handelsblatt Group’s vaccination campaign

The coronavirus pandemic has already claimed the lives of more than five million people worldwide. A far greater number are suffering from the after-effects of the disease. The vaccines available since the end of 2020 have proven to be a key component in containing Covid-19. Conzima is therefore supporting efforts to further increase the vaccination rate in Germany and, together with almost 100 (as of 08.12.2021) other companies and associations - from global corporations to small start-ups - is participating in the “! Now!” campaign of the Handelsblatt Media Group.


Both Handelsblatt (daily circulation: 128,500 copies) and Wirtschaftswoche (weekly circulation: 101,900 copies) will publish full-page advertisements in the coming days. These will show that people who have not been vaccinated are almost five times more likely to fall seriously ill with coronavirus and be hospitalized than those who have been vaccinated.
It is also clear to us: “A high vaccination rate is in the public interest,” says Conzima Managing Director Dr. Manfred Ziegler. “For us, vaccination is about much more than our own safety. It's about the common good and avoiding overloading hospitals.” The campaign will initially run until the end of the year.
Further information can be found on the Handelsblatt Group website.
Conzima Food buys the Kohrener Landmolkerei dairy

conzima Food GmbH has bought the Kohrener Landmolkerei dairy from Penig (Mittelsachsen district), which opened in 2014, out of insolvency. The purchase of the dairy is seen as the starting signal for the establishment of a small group of companies in the dairy sector. All jobs at Kohrener Landmolkerei will therefore be retained. “We need qualified and agile employees to achieve our goals, which is why we are looking forward to working with the existing workforce,” emphasizes Dr. Manfred Ziegler, Managing Director of conzima Food GmbH.


Insolvency administrator Thomas Jacobs also welcomes the sale of the dairy. Since the Kohrener Landmolkerei filed for insolvency proceedings in July, his primary goal has been the continued existence of the company: “I am particularly pleased that the modern dairy in Penig and its current 75 employees have been given a new chance for the future.”
In future, the experienced dairy manager Jörg Rögner will manage the business in Penig. “Our focus will clearly be on performance and quality leadership,” explains Rögner. “We want to firmly anchor the Kohrener Landmolkerei regional brand in the region.” The first step will be to use conzima Food GmbH's long-standing, good contacts with suppliers and customers. The aim is also to attract new customers to the project.
Dr. Ziegler sells CC Pharma and remains

CC Pharma strengthens its import business with Aphria and enters the medical cannabis market - Dr. Ziegler remains Managing Director.


CC Pharma is strengthening its import business and aims to become one of the leading suppliers of medical cannabis products for pharmacies in Germany. To this end, the company announced that the Canadian pharmaceutical company Aphria Inc. (TSX: APH) is taking over CC Pharma GmbH. “This new constellation will not only strengthen CC Pharma in the German market, but will also positively develop the pharmacy and pharmaceutical wholesale market for medical cannabis,” says Dr. Manfred Ziegler, Managing Director of CC Pharma.
CC Pharma brings extensive experience with regulatory requirements and international logistics to the new liaison with Aphria. “We are ready to deliver medical cannabis immediately,” says Dr. Ziegler. Currently, the three products he has in his pharmacy and pharmaceutical wholesale range for medicinal cannabis come from the Netherlands. In the future, further raw material suppliers will be added through Aphria. Dr. Ziegler also sees this as “necessary because the market for medicinal cannabis is still in its infancy”. Aphria International has already announced a supply agreement with CC Pharma to export around 1,200 kilograms of medicinal cannabis products from Canada to Germany.
CC Pharma is currently working with the Goslar-based pharmaceutical logistics company Med-X-Press to handle these BTM products. Med-X-Press has the expertise and the prerequisites to store sensitive pharmaceutical products in a special narcotics warehouse. The company can also map the required logistics processes.
“When pharmacies order from us, they are used to being served quickly and professionally,” says Dr. Ziegler. “And in our view, this combination of safety and expected service must be doubly and triply guaranteed for a product as sensitive as medicinal cannabis.” He is therefore pleased that CC Pharma can play a part in alleviating the supply bottlenecks in the cannabis sector for the benefit of patients with this offer.
The takeover will take effect in January 2019. Dr. Manfred Ziegler and Dr. Thomas Weppelmann, the previous owners and managing directors of CC Pharma, will remain in their roles as managing directors of the company after the takeover. As the third Managing Director, Hendrik Knopp will be responsible for the medical cannabis products division at CC Pharma. Knopp is currently Managing Director of the health care company Nuuvera Deutschland.
Dr. Ziegler: “The main business and thus the brand core of CC Pharma GmbH will remain unaffected by the acquisition. We see this as a classic addition to our portfolio because we will use our expertise from the import business to systematically tap into a new market for pharmacies and pharmaceutical wholesalers.”
Dr. Ziegler: 10 theses on the profession of Chief Restructuring Officer “CRO”

10 theses on the profession of Chief Restructuring Officer “CRO”


For whatever reason you “google” CRO, you will come across a talented German rapper with a panda mask. Only much later does the search engine also “find” “Chief Restructuring Officer”. This profession is far less glamorous than young creative rappers - and not only because the Chief Restructuring Officer (CRO) or restructuring manager or chief restructurer has to “perform” with an open visor. The profession of CRO has gradually emerged from the circle of crisis managers and interim managing directors.
Dr. Manfred Ziegler has already supported companies as a restructuring manager at a time when even experts could do little with a CRO. For more than 20 years, the managing director of conzima GmbH, based in the Allgäu region of Germany, has assumed operational responsibility for the realignment, restructuring and reorganization of companies and businesses. Ziegler is currently presenting ten theses on the CRO profession for debate. Ten theses that serve as criteria for the selection of professional restructuring managers with strong implementation skills.
1.
The requirements profile for turnaround managers has clearly taken shape.
Some financiers or shareholders have literally paid a lesson (“learning by earning”), some projects serve as a benchmark for what CROs can and should achieve. “The requirements for CROs have grown significantly in recent years and are now multi-complex,” explains Ziegler.
2.
“It goes without saying that the CRO must quickly get to grips with the figures and keep them under control. He must also have a clear idea of what these figures mean in practice for the business model, for the company and for the workforce. He must not only diagnose the figures, but also interpret them with his team in order to adapt and further develop the business model,” says Ziegler, explaining the multi-complex challenges that a CRO has to master.
3.
The classic management task is actually to adapt and further develop the business model. However, lemon butterflies do not fold lemons and managers do not always lead, but prefer to represent. The first management level is where the dignitaries sit, and the second and third levels are where the doubters are - especially in the case of change or transformation processes. The high art of leadership is required, which the professional CRO must not only know, but also master.
4.
Those who have clear concepts and ideas can lead. You can lead if you listen and define clear tasks, which are then implemented independently by the respective project teams. In dialog, not in one-way communication, to ensure permanent feedback. “Leadership is inextricably linked to designing and implementing processes, addressing and guiding employees, conveying and radiating competence,” says Ziegler.
5.
The competent CRO leads by example: “The CRO must quickly gain the trust of all stakeholders and justify this trust on a daily basis,” says Ziegler. His corresponding expertise goes far beyond understanding the product. Rather, it must penetrate the brand core, the unique selling point, the business model, in order to develop it further in a sustainable way. “As important as short-term success is,” explains Ziegler, “ultimately the business model should be able to survive in the medium and long term - and be resilient”.
6.
Competence and experience are the two sides of the CRO gold medal. “The CRO must be able to operate in several business models, in different sectors, industries or organizations,” is Ziegler's experience. Anyone who has come to know and appreciate know-how, skills and abilities from various sectors is a competent sparring partner for the top performers in the company.
7.
Part of thinking outside the box and the CRO's job profile is his network. He knows contacts and rules of the game on the financial side, with auditors and tax advisors, whom he can approach in confidence and at short notice if necessary. His network also includes entrepreneurial personalities who are sometimes considered as advisors, sometimes as potential investors. “Last but not least, the CRO must also prove to be sure-footed on the legal advisor stage and know competent, implementation-oriented lawyers in the various areas of law. This also includes the insolvency administrators and knowledge of the opportunities and risks of insolvency proceedings,” says Ziegler.
8.
Industry and service providers in Germany take advantage of their globalization opportunities. Half of SMEs are active abroad, import activities have increased significantly, foreign sales have risen sharply, the eurozone is the most important sales region, the domestic market. Consequently, the CRO must understand the different cultures in business and society: “The CRO must not be exclusively national but also international,” explains Ziegler. “Otherwise he may not even have the opportunities for the business model, for potential investors or cooperation partners fully on his radar screen.”
9.
The mandate as a restructuring manager is not for the faint-hearted. Stakeholders expect the restructuring manager to stand by his challenge with all his duties and rights. When a company is faced with a labyrinth, it expects someone in charge to guide the company through the maze with sense and understanding.
The days when consultants handed companies the blueprint for the march through the maze with a friendly “good luck” are numbered. Ziegler: “Carefully preparing the strategy, straightening your back and implementing it - this is what the various stakeholders rightly expect from a seasoned CRO today”.
10.
The field hockey stick diagram is based on a scientific study on global warming published in 1999. For many consultants, the field hockey stick effect was synonymous with hope: in the distant future, there will be a steep rise in sales or profits. The prudent CRO knows that process dynamics are never linear, that order pipelines turn out to be hot air, that stakeholders like to live the principle of hope, that new structures, new processes and new teams have to settle in. On the one hand, he is a logician, a consistent analyst who must not shy away from sacred cows. Precisely because he knows about sacred cows, about sensitivities, vanities, fears and worries, he is on the other hand emotionally highly sensitive. He must have an antenna for changing moods, he should have people in his team who question and are also allowed to hold up a mirror from time to time. Compared to young German rappers with panda masks, the tasks of a CRO are not very glamorous. Both CROs need talent - as well as the ability to constantly reinvent themselves and to fascinate, convince and entertain the respective stakeholder groups.